Associated Papers
Transmembrane domain (TM) 9 represents a novel site in P-glycoprotein that affects drug resistance and cooperates with TM6 to mediate [125I]iodoarylazidoprazosin labeling.
Song J et al.
Molecular Pharmacology, 2001
The use of a novel taxane-based P-glycoprotein inhibitor to identify mutations that alter the interaction of the protein with paclitaxel.
Gruol DJ et al.
Molecular Pharmacology, 2001
Functional evidence that transmembrane 12 and the loop between transmembrane 11 and 12 form part of the drug-binding domain in P-glycoprotein encoded by MDR1.
Zhang X et al.
The Journal of Biological Chemistry, 1995
Select a paper to view details